XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 60,873 $ 50,708
Marketable securities 62,608 106,513
Research and development tax credit receivable 2,387 2,443
Prepaid expenses and other current assets 34,873 32,826
Total current assets 160,741 192,490
Property and equipment, net 268 285
Operating lease right-of-use assets 2,410 2,652
Goodwill 16,836 16,836
Research and development tax credit receivable 1,237 1,225
Other non-current assets 39,635 33,777
Total assets 221,127 247,265
Current liabilities:    
Current portion of long-term debt 26,184 0
Current portion of operating lease liability 917 900
Accounts payable 6,048 7,679
Accrued expenses 9,432 7,151
Other current liabilities 1,442 5,270
Total current liabilities 44,023 21,000
Long-term debt 116,525 142,397
Long-term operating lease liability 1,500 1,707
Other non-current liabilities 3,847 3,917
Total liabilities 165,895 169,021
Shareholders’ equity:    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at March 31, 2022 and 488 issued and outstanding at December 31, 2021, respectively 5 5
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 59,032 issued and outstanding at March 31, 2022 and 58,620 issued and outstanding at December 31, 2021 590 586
Additional paid-in capital 553,859 549,349
Accumulated deficit (474,180) (447,756)
Accumulated other comprehensive loss (25,042) (23,940)
Total shareholders’ equity 55,232 78,244
Total liabilities and shareholders’ equity $ 221,127 $ 247,265